Skip to main content
Caplight Logo









4D Path

4D Path

Private
Newton, MassachusettsHealthcare & Life Scienceshttps://4dpath.com/

Last Round

Strategic

May 5, 2026

Total Funding Raised

$4.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

4D Path is a biotechnology company that has developed a patented, AI-powered precision diagnostics platform called the Q-Plasia OncoReader (QPOR™) to predict a patient's response to cancer treatment by analyzing digitized images from standard H&E-stained biopsies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Clinical Trials, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

digital pathologyprecision oncologycomputational pathologybiomarker discoveryAI-powered diagnosticsQ-Plasia OncoReaderQPORclinical trial supportpatient stratificationtumor microenvironmentphysics-informed AIpredictive oncologypathology AIbiopsy analysistreatment response prediction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

4D Path Comparables

Compare 4D Path with similar companies based on industry and business-model similarity.

4D Path comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Waiv
78%
Tempus
78%
Indica Labs
74%

4D Path Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicMay 5, 2026
Series AJan 24, 2023
SeedDec 10, 2019

Key People

Founding team and executive leadership

Jacopo Leonardi

Chief Executive Officer

Executive Team

Nicholas Bero

Chief Operating Officer, Chief Legal Officer

Executive Team

4D Path Investors

Notable investors and investment history

4D Path investors
InvestorRounds
ARTIS VenturesSeries A
Vesalius Biocapital PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 5, 2026

    Completed a strategic funding round.

4D Path Filings

Explore SEC and related filing metadata, where available.

4D Path filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 4D Path's valuation, stock price, and market status.

Is 4D Path a public or private company?

4D Path is a private company.

What is the current stock price of 4D Path?

4D Path is a private company with no public stock price. No recent secondary market data is available.

How much is 4D Path worth (valuation)?

Valuation information for 4D Path is not publicly available.

Can I buy 4D Path stock?

4D Path shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 4D Path's last funding round?

4D Path's most recent funding round was Strategic on May 6, 2026.

Who are the main investors in 4D Path?

Key investors in 4D Path include ARTIS Ventures.

Will 4D Path IPO soon?

No public IPO plans have been announced for 4D Path.

How can I track 4D Path secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 4D Path's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewton, Massachusetts
Employee Range15
Year Founded2016
Last FundingMay 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?